Table 4. Infectious and Noninfectious Outcomes in “Enteral Tolerant” Group.
Complications (%) | Early EN only (n = 217) | Early EN + PN (n = 32) | Adjusted OR (95% CI) | p-value |
---|---|---|---|---|
Late Infectious | ||||
Nosocomial Infection (excluding SSI) | 92 (42) | 22 (69) | 2.5 (1.1-5.9) | 0.03 |
Pneumonia | 55 (25) | 12 (38) | 1.4 (0.6-3.3) | 0.39 |
Blood Stream Infection (BSI) | 24 (11) | 10 (31) | 3.4 (1.4-8.3) | 0.007 |
Catheter Related BSI | 2 (1) | 2 (6) | 9.8 (0.9-112.9) | 0.07 |
Urinary Tract Infection | 24 (11) | 5 (16) | 1.5 (0.5-4.6) | 0.48 |
Surgical Site Infection (SSI) | 31 (14) | 6 (19) | 1.3 (0.5-3.4) | 0.65 |
Non-Infectious | ||||
Late ARDS (onset after 7 days) | 4 (2) | 3 (9) | 5.4 (1.1-27.4) | 0.04 |
Late Thromboembolic (onset after 7 days) | 15 (7) | 4 (13) | 1.7 (0.5-5.7) | 0.37 |
Death | 18 (8) | 6 (19) | 2.7 (0.8-9.3) | 0.10 |
Data are presented as number of patients in each group with percentage in parentheses. Associated p-values are based upon aOR.